Title:
PHARMACEUTICAL COMPOSITION COMPRISING TAPINAROF AND CORTICOSTEROID
Document Type and Number:
WIPO Patent Application WO/2023/109906
Kind Code:
A1
Abstract:
A pharmaceutical composition for inflammatory skin diseases, a preparation method therefor, and a use thereof in preparation of drugs for treating and/or preventing immunological, inflammatory and autoimmune diseases. The pharmaceutical composition is a cream, and comprises, by weight, 0.5%-1.5% of tapinarof or a pharmaceutically acceptable salt thereof, 0.01%-1.5% of at least one corticosteroid, 15%-50% of an oil phase matrix, 0.1%-8% of a surfactant, 5%-20% of a solvent, and/or a penetration enhancer and water.
Inventors:
MA ZHILONG (CN)
CHEN MING (CN)
JIA JIANMIN (CN)
CHEN MING (CN)
JIA JIANMIN (CN)
Application Number:
PCT/CN2022/139319
Publication Date:
June 22, 2023
Filing Date:
December 15, 2022
Export Citation:
Assignee:
THEDERMA SHANGHAI CO LTD (CN)
International Classes:
A61K31/05; A61K45/06; A61K31/573; A61P9/06; A61P17/00; A61P17/06; A61P29/00
Domestic Patent References:
| WO2021059281A1 | 2021-04-01 | |||
| WO2021100051A1 | 2021-05-27 |
Foreign References:
| US20200147000A1 | 2020-05-14 | |||
| US20210346279A1 | 2021-11-11 | |||
| CN111148729A | 2020-05-12 |
Attorney, Agent or Firm:
BEIJING ORIGINTELLIGENCE IP LAW FIRM (CN)
Download PDF: